Gardasil Vaccination in HPV-Positive Individuals

Understanding Gardasil and Its Efficacy in HPV-Positive Individuals

Gardasil is a quadrivalent vaccine that protects against HPV types 6, 11, 16, and 18, and is FDA-approved for use in both males and females, as stated by the American Academy of Otolaryngology-Head and Neck Surgery 1, 2
The vaccine is made of virus-like proteins based on the L1 capsid protein structure, which cannot cause infection even in immunocompromised individuals, according to the American Academy of Otolaryngology-Head and Neck Surgery 1
The vaccine is most effective when administered before exposure to HPV through sexual activity, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1, 2

HPV testing before vaccination is not recommended as there are no good measures of past exposure, and current testing only reflects current viral shedding, as stated by the American Cancer Society 3, 4

Women with abnormal Pap tests or positive HPV tests can receive the vaccine, though they may have diminished benefit depending on which HPV types they already have, according to the Centers for Disease Control and Prevention 5
Individuals with genital warts (typically caused by HPV 6 or 11) can still benefit from vaccination against other HPV types, as recommended by the Centers for Disease Control and Prevention 5, 6
The vaccine is safe for HPV-positive individuals, with equivalent safety demonstrated in clinical trials, as stated by the American Cancer Society 3

The potential benefit of vaccination decreases with increasing likelihood of previous HPV exposure, as stated by the American Cancer Society 3, 4
Individuals with multiple sexual partners have higher likelihood of exposure to multiple HPV types, according to the American Cancer Society 3, 4
Continued cervical cancer screening is essential for women regardless of vaccination status, as recommended by the Centers for Disease Control and Prevention 6